The developed methods were studied concerning the effect of the pH, dye volume, Cr 6+ :dye ratio, stability of the colored complex, etc. for methods I and II, while ) from a multi-vitamin with multi-mineral pharmaceutical formulations were developed. The proposed methods are based on the conversion of Cr 3+ to Cr 6+ either by oxidation with a nitric acid-perchloric acid mixture (method I) or by fusion with an excess amount of sodium carbonate (method II), followed by the complexation of Cr 6+ with 1,5-diphenylcarbazide (DPC) in a mineral acidic solution of pH 1.0 ± 0.5. The pink-colored complex was estimated at 544 nm. Both methods were found to be linear in the range of 0.1 -0.8 µg/ml with a limit of detection in the range of 0.0123 -0.0157 µg/ml and a limit of quantitation in the range of 0.0419 -0.0525 µg/ml. Method I was found to be suitable for estimating Cr 3+ species in various formulations, like tablets, capsules and syrups, while method II was found to be suitable for tablets and capsules. Satisfactory recovery from spiked samples of standard Cr 3+ suggests no interference of any excipients and diverse ions present in the formulations. The developed methods were compared with AAS by ANOVA, and no significant difference was observed.
Introduction
Chromium (Cr) can exist in various chemical valence states ranging from Cr 2+ to Cr
6+
, among which more stable chemical forms are Cr 3+ and Cr 6+ . Cr 3+ is relatively non-toxic and is an essential nutrient in the human diet to maintain effective glucose, lipid and protein metabolism. 1 However, Cr 6+ is primarily anthropogenic and, as CrO4 2-or HCrO 4-, can diffuse through cell membranes and oxidize biological molecules with toxic results. 2 Cr 6+ has been classified by the International Agency for Research on Cancer (IARC) as a Group I human carcinogen 3 and by the US Environmental Protection Agency (EPA) as a Group A inhalation carcinogen. 4 Chromium is one of the essential trace elements in multivitamin with multi-mineral pharmaceutical formulations that contain only Cr 3+ either in the form of chromium chloride (inorganic source) or chromium picolinate and chromium polynicotinate (organic source). The methods for estimating Cr 3+ from pharmaceutical formulations are atomic absorption spectroscopy (AAS) and graphite furnace AAS (GF-AAS). Other methods reported in the literature for estimating Cr 3+ are chemiluminescence analysis, flame AAS, X-ray fluorescence spectroscopy (XRFS) and colorimetric from air. 5 Various methods for estimating Cr 6+ and total Cr include flow-injection flame AAS from industrial effluents; turbidimetry; ion chromatography; anion-exchange chromatography; HPLC with diode array detection (HPLC-DAD) from environmental matrices; fast protein liquid chromatography (FPLC); thermal lens spectrometry (TLS); X-ray fluorescence; AAS from black tea and tea leaves, food, dietary products, lung tissues, standard alloys and biological samples; zeeman AAS from blood and serum; electro thermal AAS (ETAAS) from cocaine samples; AAS-flame emission spectrophotometry (AAS-FES) from ancient Perivian hair; mass spectroscopy (MS) from metal allergenic substances on skin; inductively coupled plasma-mass spectrometry (ICP-MS) from seawater; ICP-atomic emission spectroscopy (ICP-AES) from human gallstone; neutron activation analysis (NAA) from biological specimens, tissue surroundings, blood and milk; electron spin resonance (ESR) from rat blood; scanning electron microscopy (SEM), transmission electron microscopy (TEM) and electron probe microanalyses (EPMA) from metal-bearing contaminated soil and industrial waste; colorimetric methods 6 from shrimp feed, 7 air, 8,9 urine 8,10,11 and catgut suture, 12 etc. Not even a single spectroscopic method has been reported for estimating Cr 3+ from pharmaceutical formulations. Thus the primary objective of the present work was to develop, optimize and validate sensitive, selective, precise, accurate, costeffective, and simple spectroscopic methods.
The proposed methods are based on removing all organic matter of a multi-vitamin with multi-mineral pharmaceutical formulations by heating in a muffle furnace 13 at 550˚C -600˚C for 6 -7 h. Cr 3+ was converted to Cr 6+ by oxidation with a nitric acid-perchloric acid mixture 13 (method I) and by fusion with excess of sodium carbonate 14 (method II), followed by estimating a pink-colored complex in a mineral acidic solution of pH 1.0 ± 0.5 at 544 nm obtained by the reaction of Cr 6+ with 1,5-diphenylcarbazide (DPC), which is considered to be one of the most sensitive and selective reactions for Cr 6+ determination.
the Na2CO3 composition, heating time were considered for method II.
Experimental

Apparatus
A Shimadzu UV-VIS spectrophotometer (Model UV-1601) with matched 1 cm silica cells was used for all spectral and absorbance measurements.
The glassware used in each procedure was soaked overnight in a chromic mixture (K2Cr2O7 + concentrated H2SO4), rinsed thoroughly with double-distilled water and dried in dust-free air. Whatman filter paper No. 42 was used to filter solutions of different formulations to separate them from the solvent immiscible formulation excipients.
Reagents
Double-distilled water and analytical-reagent grade chemicals were used. Standard solutions of chromium were prepared by using chromium chloride hexahydrate (CrCl3·6H2O) or chromium picolinate (C18H12N3O6Cr) salts. A Cr 6+ complexing reagent solution of 1,5-diphenylcarbazide (DPC) (S. D. Fine Chem Ltd., Mumbai, India) was prepared by dissolving 0.25 g of DPC in 50 ml of acetone, and stored in an amber-colored bottle. This solution was discarded when it became slightly colored, and should not be used after 48 h of its preparation; it is always preferable to use it freshly prepared.
Preparation of standard solution for calibration curve (method I)
Chromium salts (chromium chloride hexahydrate or chromium picolinate) equivalent to 1.0 mg of Cr 3+ were subjected to heating in a muffle furnace in a silica crucible at about 550˚C for 6 -7 h; the ash was then dissolved in 0.2 M sulfuric acid (pH 1 ± 0.5) in order to obtain a stock solution of 5 µg/ml of Cr
6+
. From this stock solution, suitable aliquots were taken and 0.2 ml of DPC dye was added to each, allowed to stand for 5 min for full color development and volume was made up to 10 ml with distilled water to obtain the final concentration in the range of 0.1 to 0.8 µg/ml; the absorbance was measured at 544 nm.
Preparation of standard solution for calibration curve (method II)
In method II, chromium salts (chromium chloride hexahydrate or chromium picolinate) equivalent to 1.0 mg of Cr 3+ along with sodium carbonate (Na2CO3) equivalent to 5-times its weight were heated in a muffle furnace in a silica crucible at about 550˚C for 6 -7 h, and then the ash was dissolved in about 100 ml of water, boiled on a water-bath for about 45 min, cooled and filtered. The pH of the filtrate was adjusted at around 1 ± 0.5 and the volume was made to obtain 5 µg/ml of Cr
6+
. From this stock solution, suitable aliquots were taken and 0.2 ml of DPC dye was added to each, allowed to stand for 5 min for full color development and the volume was made up to 10 ml with distilled water to obtain the final concentration in the range of 0.1 to 0.8 µg/ml; the absorbance was measured at 544 nm.
Preparation of a sample solution (method I)
After twenty tablets/capsules were weighed and triturated, a powder equivalent to 1.0 mg of Cr 3+ was subjected to heating in a muffle furnace as per the conditions stated under "Preparation of standard solution for calibration curve (method I)". The ash was then digested with 30 ml of a nitric acid-water-perchloric acid mixture (5:5:20 v/v/v) on a burner until white fumes of perchloric acid started to appear, became vigorous and then ceased. This solution was allowed to cool, and was diluted with distilled water; the pH was adjusted at 1 ± 0.5 and the volume was made to obtain a final concentration of 5 µg/ml of Cr 6+ to proceed further, as mentioned above.
Preparation of a sample solution (method II)
After twenty tablets/capsules were weighed and triturated, a powder equivalent to 1.0 mg of Cr 3+ was mixed with sodium carbonate (Na2CO3) equivalent to 5-times the weight of the sample taken, mixed/triturated well and then subjected to heating in a muffle furnace, as described under "Preparation of standard solution for calibration curve (method II)". The ash was dissolved in about 100 ml of water and boiled on a waterbath for about 45 min, cooled and filtered. The pH of the filtrate was adjusted at around 1 ± 0.5, and the volume was made to obtain 5 µg/ml of Cr 6+ to proceed further, as mentioned above.
Results and Discussion
Absorption spectra
The absorption spectra of a Cr 6+ -DPC dye complex are graphically presented in Fig. 1 . As can be seen, the complex has its maximum absorbance at 544 nm.
Effect of the Na2CO3 composition (method II)
The Na2CO3 composition in method II is a very critical parameter, which was investigated for optimum conditions. Na2CO3 equivalent to 4-times, 5-times and 6-times of the : dye complex at 0.1 µg/ml (a), 0.2 µg/ml (b), 0.3 µg/ml (c), 0.4 µg/ml (d), 0.5 µg/ml (e), 0.6 µg/ml (f), 0.7 µg/ml (g) and 0.8 µg/ml (h) concentration levels. Fig. 2 Optimization of the Na2CO3 composition using chromium chloride as a standard.
sample weight was taken for both of the chromium salts (i.e. chromium chloride or chromium picolinate). The same process was applied to all of the samples, and the absorbance at 544 nm was measured. Na2CO3 equivalent to 5-times the sample weight was found to be the optimum composition for the complete oxidation of Cr 3+ to Cr 6+ . Below this level, oxidation was incomplete and above this level it was interfered. This was further correlated from the results shown in Fig. 2 , where a Na2CO3 equivalent to 5-times the sample weight showed the maximum absorbance for both salts.
Effect of the heating time (method II)
Because boiling the ashed samples with 100 ml of water in a water-bath is required for complete conversion of Cr 3+ to Cr 6+ in method II, the effect of the boiling time was studied with different time intervals of 15, 30, 45 and 60 min. As shown in Fig. 3 , boiling for less than 45 min was insufficient for complete conversion, and boiling for more than 45 min yielded in less % label claim. Hence, a boiling time of 45 min was found to be optimum, because it showed the maximum % label claim for both salts.
Effect of the pH (methods I and II)
For the stability of the oxidized Cr 6+ species, an acidic environment is essential. Organic compounds and alkaline condition can cause Cr 6+ reduction to Cr 3+ , which will not form a complex with DPC dye. This was confirmed by maintaining different pH values (0.1, 0.33, 0.5, 0.75, 1, 1.2, 1.4, 1.6, 1.8, 2, 3, 5, and 6.8) of a solution containing the same concentration of oxidized Cr 6+ species (0.7 µg/ml). The color intensity of the Cr 6+ :dye complex was drastically reduced as the pH increased, and because it was almost constant over the range of 1 ± 0.5, it was selected as being optimum. The results for chromium chloride salt for both methods are shown in Fig. 4 .
Effect of the dye volume (methods I and II)
For evaluating the effect of the dye volume, different aliquots (0.05, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, 0.8, 1, and 1.5) of 0.5% w/v DPC in acetone were taken for the same concentration of Cr 6+ (0.7 µg/ml). A dye volume of 0.2 ml of 0.5% w/v was found to be optimum for both salts, because at less volume the dye quantity was insufficient to form a Cr 6+ :dye complex, and at higher volumes of the dye, the complex formation was interfered. As presented in Fig. 5 , it showed the maximum absorbance at 0.2 ml of dye volume for chromium chloride salt for both methods.
Chromium (Cr
6+ ):dye ratio (Job's plot)
In order to determine the Cr 6+ :dye ratio, equimolar (0.0004 M) solutions of chromium (Cr 6+ , chromium chloride used as a standard salt) and DPC dye were prepared and different mole fractions of chromium and dye were taken. The absorbance was plotted against mole fraction of DPC to determine the ratio. This plot is called Job's plot. As shown in Fig. 6 , Cr 6+ :dye ratio of 3:7 showed the maximum absorbance, indicating a 1:2 complex for both methods.
Stability of colored complex
No significant change was observed in the absorbance for up to 3 h, but a significant reduction in absorbance during the forth hour indicated the stability of the colored complex to be of 3 h.
Calibration curve, sensitivity and validation
Under the recommended conditions, the system obeys Beer's 1323 ANALYTICAL SCIENCES SEPTEMBER 2004, VOL. 20 Fig. 3 Optimization of the heating time using chromium chloride as a standard. Fig. 4 Effect of the pH using chromium chloride as a standard. a, Method I; A, Method II. law over the concentration range of 0.1 -0.8 µg/ml for both salts and for both methods with an RSD of less than 1% at each concentration level. The low values of the standard error and the coefficient of variation establish the precision of the proposed methods.
Other parameters, like the molar absorptivity, Sandell's sensitivity, regression equation, coefficient of determination (r 2 ), correlation coefficient (r), limit of detection (LoD), limit of quantitation (LoQ), etc. are given in Table 1 . The obtained correlation coefficient values are highly significant for both methods. Inter-day and intra-day RSD were also found to ascertain the precision of the developed methods. As shown in Table 2 , RSD did not exceed 2% in any case. Recovery studies were carried out to ascertain the accuracy and precision of the methods by spiking the samples with known amounts of standard chromium salt to previously analyzed the samples. Good recoveries of the analytes were attained (Table  3) with RSD less than 2.0%.
Effect of diverse ions on the determination of chromium
For studying the effect of diverse ions, a homogenous mixture containing various ions (like zinc, manganese, copper, iron, silicon, selenium, iodide, molybdenum, vanadium, etc.) in different forms was prepared containing standard chromium salt (chromium chloride) in a known quantity; the estimation was carried in the presence of interfering ions in order to judge whether the estimation is interfered or not. Good recovery for the added salt, as shown in Table 4 , indicated no interference of the diverse ions on the estimation of chromium.
Application
The developed methods can be successfully applied for estimating Cr 3+ from various pharmaceutical multi-vitamins with multi-mineral formulations, such as tablets, capsules and syrups. However, method II is applicable for estimating Cr 3+ from tablets and capsules.
The analyses of various pharmaceutical formulations are enumerated in Table 5 .
Comparison with AAS
The results of method I, method II and AAS 13 were compared statistically by ANOVA. The reported F value, as given in Table 6 , of a two-way ANOVA test for difference between methods, suggests that there is no significant difference.
From the discussion above, it is clear that the developed methods are accurate, precise, repeatable, reproducible, linear, quicker, inexpensive, sensitive and simple. Therefore, the proposed methods make them useful in the routine and quality control analysis of multi-vitamins with multi-mineral pharmaceutical formulations.
Moreover, no significant Table 2 Inter-day (n = 3) and intra-day (n = 6) precision and accuracy a. Average of three and six determinations at two concentration level for inter-day and intra-day, respectively. Intra-day (n = 6) difference was observed between the developed methods and the pharmacopoeial method (AAS).
Method
